Edgewise Therapeutics, Inc. EWTX Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s other commercial liabilities?
- Edgewise Therapeutics, Inc. (EWTX) reported other commercial liabilities of $8.56M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s other commercial liabilities changed year-over-year?
- Edgewise Therapeutics, Inc.'s other commercial liabilities increased by 16.4% year-over-year, from $7.35M to $8.56M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s other commercial liabilities has grown at a 37.9% compound annual growth rate (CAGR), from $1.59M to $7.92M.